Compare ATRA & NTIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATRA | NTIC |
|---|---|---|
| Founded | 2012 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Specialties |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 81.2M | 81.9M |
| IPO Year | 2014 | 1996 |
| Metric | ATRA | NTIC |
|---|---|---|
| Price | $9.00 | $8.07 |
| Analyst Decision | Sell | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $5.00 | N/A |
| AVG Volume (30 Days) | ★ 44.7K | 5.2K |
| Earning Date | 05-13-2026 | 04-09-2026 |
| Dividend Yield | N/A | ★ 0.49% |
| EPS Growth | ★ 122.52 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $120,772,000.00 | $84,234,474.00 |
| Revenue This Year | N/A | $12.49 |
| Revenue Next Year | N/A | $7.64 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.92 | $7.25 |
| 52 Week High | $19.15 | $10.03 |
| Indicator | ATRA | NTIC |
|---|---|---|
| Relative Strength Index (RSI) | 51.47 | 46.42 |
| Support Level | $9.03 | $7.86 |
| Resistance Level | $11.17 | $9.00 |
| Average True Range (ATR) | 0.66 | 0.13 |
| MACD | 0.08 | -0.00 |
| Stochastic Oscillator | 62.01 | 8.04 |
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA3431, and ATA3219.
Northern Technologies International Corp is a United States-based firm that develops and markets proprietary, environmentally beneficial products and services world wide either directly or through a network of joint ventures, distributors, and agents. It operates through two segments, which include ZERUST products and services and Nature-Tec products. Its main business is providing corrosion prevention solutions that are marketed under the ZERUST brand. The company also sells a portfolio of bio-based and biodegradable (compostable) polymer resin compounds and finished products marketed under the Nature-Tec brand. The ZERUST brand generates a vast majority of the revenue for the company. The company generates the majority of its revenue in the United States.